Bactericidal activity against intermediately cephalosporinresistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 2050-2052

  Doit, Catherine ^a   Barre, Jerome ^b   Cohen, Robert ^b   Bonacorsi, Stephane ^a   Bourrillon, Antoine ^a   Bingen, Edouard H ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEPHALOSPORIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; INFANT; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030850410     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.2050     Document Type: Article

References (21)

1. Asmar, B. I., M. C. Thirumoorthi, J. A. Buckley, D. M. Kobos, and A. S. Dajani. 1985. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. Antimicrob. Agents Chemother. 28:138-140.
2. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob. Agents Chemother. 40:1973-1976.
3. Bauchet, J., E. Pussard, and J. J. Garaud. 1987. Determination of vancomycin in serum and tissues by column liquid chromatography using solid-phase chromatography. J. Chromatogr. 414:472-476.
4. Bingen, E., N. Lambert-Zechovsky, P. Mariani-Kurkdjian, C. Doit, Y. Aujard, F. Fournerie, and H. Mathieu. 1990. Bacterial count in cerebrospinal fluid of children with meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 9:278-281.
5. Committee on Infectious Diseases. 1988. Treatment of bacterial meningitis. Pediatrics 81:904-907.
6. Demotes-Mainard, F. M., G. A. Vincon, C. H. Jarry, and H. C. Albin. 1984. Micromethod for the determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography. J. Chromatogr. 336:438-445.
7. Doit, C., E. Denamur, B. Picard, P. Geslin, J. Elion, and E. Bingen. 1996. Mechanisms of spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France. J. Infect. Dis. 174:520-528.
8. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
9. Friedland, I. R., M. Paris, S. Shelton, and G. H. McCracken, Jr. 1993. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 34:231-237.
10. Geslin, P. 1996. Centre National de Référence des Pneumocoques: rapport d'activité année 1994-1995. Centre National de Référence de Pneumocoques.
11. Gilchrist, J. E., J. E. Campbell, C. B. Donnely, J. T. Peller, and J. M. Delaney. 1973. Spiral plate method for bacterial determination. Appl. Environ. Microbiol. 25:244-252.
12. John, C. C. 1994. Treatment failure with the use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 18:188-193.
13. Jones, R. N. 1995. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review. Diagn. Microbiol. Infect. Dis. 22:19-33.
14. Klugman, K. P., I. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
15. Lebel, M. H., and G. H. McCracken, Jr. 1989. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics 83:161-167.
16. McCracken, G. H., Jr., and Y. Sakata. 1985. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob. Agents Chemother. 27:141-145.
17. National Committee for Clinical Laboratory Standards. 1994. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3, vol. 14, no. 16. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Paris, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
19. Schaad, U. B., G. H. McCracken, Jr., C. A. Loock, and C. L. Thomas. 1981. Pharmakcokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J. Infect. Dis. 143:156-163.
20. Trang, J. M., R. F. Jacobs, G. L. Kearns, A. L. Brown, T. G. Wells, F. L. Underwood, and R. B. Kluza. 1985. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob. Agents Chemother. 28:791-795.
21. Viladrich, P. F., C. Cabellos, R. Pallares, F. Tubau, J. Martínez-Lacasa, J. Liñares, J., and F. Gudiol. 1996. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:218-220.